Zai Lab LTD Form 4 insider transactions

NASDAQ
Rafael Amado, a Zai Lab executive, reports the acquisition and disposal of American Depositary Shares (ADS) related to vesting Restricted Share Units (RSUs).
NASDAQ
Frazor Titus Edmondson III, Chief Legal Officer of Zai Lab Ltd, reports the acquisition and disposal of American Depositary Shares (ADS) due to stock option grants and vesting of Restricted Share Units (RSUs).
NASDAQ
Harald Reinhart, a Zai Lab executive, reports the acquisition and disposal of American Depositary Shares (ADS) and stock options.
NASDAQ
Zai Lab's Chairperson and CEO, Du Ying, reports acquisition and disposal of American Depositary Shares (ADS) related to vesting of Restricted Share Units (RSUs).
NASDAQ
Yajing Chen, CFO of Zai Lab Ltd, reports the acquisition of stock options and restricted share units, as well as the sale of American Depositary Shares (ADS) to cover taxes.
NASDAQ
Rafael Amado, a Zai Lab executive, reports the acquisition of stock options and restricted share units in the company.
NASDAQ
Joshua L. Smiley, President and COO of Zai Lab, reports the acquisition of stock options and restricted share units.
NASDAQ
Rafael Amado, a Zai Lab executive, reported selling 2,544 American Depositary Shares (ADS) at $18.86 each on March 15, 2024, under a pre-arranged trading plan.
NASDAQ
Frazor Titus Edmondson III, Chief Legal Officer of Zai Lab Ltd, sold 10,000 American Depositary Shares (ADSs) at an average price of $18.7127 on March 15, 2024, under a pre-arranged Rule 10b5-1 trading plan.
NASDAQ
Zai Lab's Chairperson and CEO, Du Ying, reported transferring a total of 33,891 American Depositary Shares (ADS) to a trust for her adult son and directly to her adult son on March 13, 2024.
NASDAQ
Joshua Smiley, COO of Zai Lab, purchased 3,000 American Depositary Shares (ADSs) at $20.83 each on March 1, 2024, under a pre-arranged Rule 10b5-1 trading plan.